Dr. Marc H. Levy, MD

Dr. Levy practices at Sarasota Retina Institute P A in Sarasota, Florida.

Dr. Levy's NPI, 1922051663, was assigned on May 17, 2006. Dr. Levy graduated from University of Miami, Miller School of Medicine in 1981. Dr. Levy holds Florida license ME43426.

Dr. Levy's primary practice is Sarasota Retina Institute P A, at 3400 Bee Ridge Rd, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 921-5335.

Dr. Levy's primary practice is Sarasota Retina Institute P A in Sarasota, Florida. Dr. Levy is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. Dmand AI also links Dr. Levy to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levy practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Levy's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Levy is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Levy's licenses on file in 3 states: Florida, Louisiana and Alabama.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Levy treats.

CMS data shows 14,713 Medicare services from Dr. Levy across 28 procedure codes in 2024, for 889 Medicare patients. Medicare paid $514,635 for them.

CMS counts 889 Medicare patients who saw Dr. Levy in 2026. The largest group is 75 to 84, with 380 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levy's median patient age at 76, with 56% women.

In 2026, Dr. Levy wrote 1,266 Medicare Part D claims for 350 patients. 73% of them were for generic drugs. CMS names the drug for 1,084 of them, across 22 drugs with 11 or more claims each, at $96,550 in total drug cost. In 2023, CMS named 1,103 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Levy for performance year 2026, reported as part of a group. Dr. Levy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of cataract surgery by Dr. Levy, more than 70% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Levy, published from 2015 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Firearms, Wounds, Gunshot and Homicide. Dr. Levy has published most often in Am J Ophthalmol. Dr. Levy's most frequent co-authors are Curtis E. Margo, MD, Deborah A. Kuhls, MD and Joseph V. Sakran, MD, MPH.

Dmand AI links Dr. Levy to 3 clinical trials. Conditions studied include Keratoconus, Dilatation, Pathologic and Optic Neuropathy, Ischemic. Cxlusa sponsors the most, 2.

CMS Open Payments shows 234 general payments to Dr. Levy from 39 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. VisionCare Inc. paid the most, $9,714.

Dr. Levy graduated from University of Miami, Miller School of Medicine in 1981.

Dr. Levy is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.